Hitting parasites where they hurt: New research shows promise in the fight against Toxoplasmosis

May 21, 2012 by James Hataway, University of Georgia

Toxoplasmosis, a disease caused by the parasite Toxoplasma gondii, is one of the most common parasitic infections in the world. In the U.S. it is estimated that more than 22 percent of the population 12 years and older have been infected with toxoplasma, according to the Centers for Disease Control and Prevention.

Now, thanks in part to a five-year, $1.8-million grant from the National Institutes of Health, University of Georgia researcher Silvia Moreno has identified a potential target for new therapies against toxoplasma infection, which may help to protect people with compromised immune systems, developing and other sensitive populations from serious harm.

Toxoplasma works by invading healthy cells within the body, and once it has taken over, the cell's membranes protect the parasite from the . However, as it replicates and fills the cell, some parasites must venture out to find new cells to attack. It is during this process, when toxoplasma is outside the protective walls of the , that Moreno sees an opportunity to combat the parasite.

"We are interested in knowing how the parasite is able to survive long enough to find another host cell," said Moreno, professor of in the UGA Center for Tropical and Emerging Global Diseases and the Franklin College of Arts and Sciences.

Moreno's lab found that while toxoplasma is outside the protective host cell, it develops a large internal organelle called a vacuole that they think may protect the parasite and help it prepare to invade the next cell. Moreno and her collaborators call the organelle a "plant-like vacuole" because it bears resemblance to similar in plants.

"We think there are stresses the parasite encounters when it is outside, so it needs a mechanism to survive that shock," Moreno said. "At the same time, the parasite has to get ready to infect another cell; it needs to secrete proteins that will help it attach to the cell and invade."

For this vacuole to become a target, scientists must first understand the parasite's basic behaviors and biological functions. They can then start to create new therapies.

"We don't want to know how the parasite behaves just for the fun of it; we want to know where we can hit it," Moreno said. "That's the reason we study its biology because we want to know exactly where to hit toxoplasma with drugs."

Disrupting the function of the plant-like vacuole may render the parasite incapable of movement. If toxoplasma cannot safely leave the confines of a host cell, it cannot replicate and it cannot create a widespread infection.

Most people infected with toxoplasma are relatively safe from danger because the immune system is able to seek out and destroy the parasite before it causes harm.

"The parasite is very smart in that it does not kill healthy people," Moreno said. "If you are a parasite, you don't want to kill your host, because if you kill your host you're done too."

But toxoplasma can be incredibly dangerous to those with compromised immune systems, such as AIDS or chemotherapy patients, and to a fetus whose mother has been exposed to the parasite. In these situations, toxoplasma invades human cells and begins replicating, leaving behind cysts that damage brain and muscle tissue.

Moreno also said that toxoplasma serves as an excellent research and teaching tool because the plant-like vacuole may be present in the large and diverse group of animal called apicomplexans, which are the cause of several important infectious human diseases, including malaria. She said the lessons learned from toxoplasma could be useful in the treatment of these diseases.

Explore further: Mice infected with Toxoplasma gondii parasite show Alzheimer's improvements

Related Stories

Mice infected with Toxoplasma gondii parasite show Alzheimer's improvements

March 21, 2012
The parasite Toxoplasma gondii has some favorable effects on the pathogenesis and progression of a mouse model of Alzheimer's disease, reports a Mar. 21 study in the open access journal PLoS ONE.

Recommended for you

Scientists solve the case of the missing subplate, with wide implications for brain science

June 21, 2018
The disappearance of an entire brain region should be cause for concern. Yet, for decades scientists have calmly maintained that one brain area, the subplate, simply vanishes during the course of human development. Recently, ...

LincRNAs identified in human fat tissue

June 21, 2018
A large team of researchers from the U.S. and China has succeeded in identifying a number of RNA fragments found in human fat tissue. In their paper published in the journal Science Translational Medicine the group describes ...

Key molecule of aging discovered

June 21, 2018
Every cell and every organism ages sooner or later. But why is this so? Scientists at the German Cancer Research Center in Heidelberg have now discovered for the first time a protein that represents a central switching point ...

Compound made inside human body stops viruses from replicating

June 20, 2018
The newest antiviral drugs could take advantage of a compound made not by humans, but inside them. A team of researchers has identified the mode of action of viperin, a naturally occurring enzyme in humans and other mammals ...

Research reveals zero proof probiotics can ease your anxiety

June 20, 2018
If you're expecting probiotics to reduce your anxiety, it might be time to put down that yogurt spoon—or supplement bottle—and call a professional instead.

Long-term estrogen therapy changes microbial activity in the gut, study finds

June 20, 2018
Long-term therapy with estrogen and bazedoxifene alters the microbial composition and activity in the gut, affecting how estrogen is metabolized, a new study in mice found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.